Quethera has secured an undisclosed amount of funding from the University of Cambridge Enterprise Fund III.
Quethera, a pharmaceutical spinout of University of Cambridge, has secured an undisclosed amount of funding from the University of Cambridge Enterprise Fund III.
The fund was launched by Cambridge Enterprise, University of Cambridge’s tech transfer office, and is managed by Parkwalk Advisors.
Quethera is developing a treatment for glaucoma, a disease of the eye that is a leading cause for blindness and particularly affects the elderly population. The development is still in its early-stage and so far has been confined…
